Sponsors (11)
The bill aims to improve veteran safety and VA care quality through a rapid, public review of prescribing and suicide patterns, but it risks patient privacy, reputational harm to facilities, resource strain, and unintended limits on medication access unless data protections, funding, and careful implementation accompany the effort.
Veterans receiving VA care: A mandated comprehensive review of VA prescribing, diagnoses, and suicide outcomes will identify patterns and facility hotspots and reveal dangerous prescribing practices, enabling targeted actions to reduce veteran suicides and improve medication safety.
VA clinicians and policymakers: Publication of findings and recommendations can inform updates to clinical guidelines, training, and quality-improvement efforts, improving care delivery across the VA system.
Families, taxpayers, and Congress: Requiring reports to Congress and posting results publicly increases transparency and oversight of VA practices, which can build trust and enable accountability.
Veterans: Public listing of medications and diagnoses risks re-identification and privacy breaches if the data are not sufficiently de-identified before release.
VA patients and facilities: Identifying facilities with high prescribing or suicide rates can cause reputational harm, trigger increased scrutiny, and lead to resource reallocation that may affect local care delivery.
VA resources and federal budget: Completing a comprehensive review within 18 months will require staff time and funding, potentially diverting resources from clinical services unless additional funds are provided.
Based on analysis of 2 sections of legislative text.
Introduced December 18, 2025 by Andrew R. Garbarino · Last progress December 18, 2025
Requires the Department of Veterans Affairs to complete a public, comprehensive review within 18 months of enactment of deaths by suicide among veterans who received VA care in the five years before their death. The review must count suicides, summarize decedents by demographics, list medications prescribed and detected (including high-risk and psychotropic drugs), summarize diagnoses that led to prescriptions, identify concurrent prescriptions, document trauma and combat history, flag facilities with unusually high prescription and suicide rates, describe VA prescribing policies, identify observed patterns, and provide recommendations to improve veteran safety and care. The Act also includes a short naming provision only.